Urea volume of distribution exceeds total body water in patients with acute renal failure

被引:53
作者
Himmelfarb, J
Evanson, J
Hakim, RM
Freedman, S
Shyr, Y
Ikizler, TA
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Div Biostat, Nashville, TN USA
[3] Maine Med Ctr, Div Nephrol, Portland, ME 04102 USA
关键词
hemodialysis; kinetics; dialysis dose; anthropomorphic body water; acute renal failure; RRT; urea kinetic modeling;
D O I
10.1046/j.1523-1755.2002.00118.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background An accurate estimate of volume of distribution of urea (V-urea) is critically important to guide the prescription of therapy and the quantification of delivered dialysis dose in patients with chronic and acute renal failure (ARF). While V-urea has been shown to be substantially the same as total body water (TBW) in other patient populations, this relationship has not been adequately studied in detail in ARF patients. Methods: To evaluate this question, we undertook a systematic study of these parameters in a cohort of 28 patients with ARF to analyze methods of estimating V-urea and TBW using blood-based kinetic data, anthropometric data and bioelectrical impedance analysis (BIA). Results. The results show that V-urea estimated by double-pool Kt/V (67.9 +/- 19.2 L) and by equilibrated Kt/V (61.2 +/- 13.6 L) were statistically significantly higher than V-urea determined by single-pool Kt/V (55.3 +/- 12.9 L; difference of 16% and 11%, respectively). Determination of TBW by anthropometric measurements (Watson, 42.5 +/- 7.0 L; Hume-Weyer, 43.6 +/- 7.1 L; Chertow, 46.8 +/- 8.1 L) yielded significantly lower measures compared to TBW determined by physiological formulae and by BIA (51.1 +/- 11.6 L and 51.1 +/- 13.3 L, respectively). Most importantly, all measures of V-urea by blood-based kinetics exceeded TBW measurements by any method (7% to 50% difference). Conclusion. Our results suggest that in terms of useful guidelines to prescribe a specific dose of dialysis in patients with acute renal failure, estimates of TBW cannot be used as a surrogate for V-urea in determining dialysis adequacy.
引用
收藏
页码:317 / 323
页数:7
相关论文
共 30 条
[1]   Changing acute renal failure treatment from intermittent hemodialysis to continuous hemofiltration: impact on azotemic control [J].
Bellomo, R ;
Farmer, M ;
Bhonagiri, S ;
Porceddu, S ;
Ariens, M ;
M'Pisi, D ;
Rongo, C .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1999, 22 (03) :145-150
[2]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[3]   Development of a population-specific regression equation to estimate total body water in hemodialysis patients [J].
Chertow, GM ;
Lazarus, JM ;
Lew, NL ;
Ma, LH ;
Lowrie, EG .
KIDNEY INTERNATIONAL, 1997, 51 (05) :1578-1582
[4]   Bioimpedance norms for the hemodialysis population [J].
Chertow, GM ;
Lazarus, JM ;
Lew, NL ;
Ma, LH ;
Lowrie, EG .
KIDNEY INTERNATIONAL, 1997, 52 (06) :1617-1621
[5]  
Clark W R, 1997, Adv Ren Replace Ther, V4, P64
[6]  
CLARK WR, 1994, J AM SOC NEPHROL, V4, P1413
[7]   Renal replacement therapy quantification in acute renal failure [J].
Clark, WR ;
Mueller, BA ;
Kraus, MA ;
Macias, WL .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 :86-90
[8]  
CLARK WR, 1992, ASAIO J, V38, P664
[9]  
Dahl NV, 1999, KIDNEY INT, V56, P2297
[10]  
DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205